Lv11
78 积分 2024-09-01 加入
Targeting aging mechanisms: pharmacological perspectives
1小时前
已完结
Gene therapy targeting the blood-brain barrier
22天前
已完结
Evaluation of the pharmacokinetics of TV-44749, newly developed once-monthly extended-release formulation of olanzapine in healthy volunteers and patients with schizophrenia
1个月前
已完结
Central natriuretic peptide receptor (NPR)-B and peripheral lipid accumulation
1个月前
已完结
Novel Pyrido[3,4-d]pyrimidin-4-one and Pyrimido[5,4-d]pyrimidin-4-one Derivatives as TREM2 Agonists for Treating Parkinson’s Disease
2个月前
已完结
Role of TREM2 in immune and neurological diseases: Structure, function, and implications
3个月前
已完结
A Phase 1 Study to Evaluate the Pharmacokinetics of Single High Doses of Iptacopan
3个月前
已关闭
HRS-5965, a small-molecule factor B inhibitor, in healthy participants and participants with renal insufficiency: A first-in-human, phase 1 trial
3个月前
已关闭
A First-in-Human, Phase 1 Study to Assess the Pharmacodynamic Properties of Single-Dose Iptacopan (CLNP023X2101)
5个月前
已完结
Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study
8个月前
已完结
皖公网安备34019202002308
